Literature DB >> 2851485

A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes.

B E Coupar1, M E Andrew, D B Boyle.   

Abstract

Plasmid vectors with multiple cloning sites adjacent to a vaccinia virus (VV) promoter were constructed and used to insert a protein coding sequence and a dominant selectable marker into a non-essential region of the VV genome. Recombinant viruses, selected on the basis of expression of the herpes simplex virus (HSV) thymidine kinase gene (tk), were shown to express in infected cells the model gene product, murine major histocompatibility complex (MHC) antigen H-2Kd, by cell-surface binding of antibody and by MHC-restricted recognition by cytotoxic T lymphocytes. Double recombinant VVs with insertions at two sites (in the VV tk gene and in the VV HindIII-F region) were constructed and shown to express influenza A/PR/8/34 haemagglutinin and H-2Kd antigen in addition to the HSV tk gene. The plasmids described allow the construction of recombinant VV expressing two genes of interest under the control of the same VV promoter. Such recombinant VVs can be used to study the interaction of immunologically important antigens simultaneously expressed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851485     DOI: 10.1016/0378-1119(88)90593-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  16 in total

1.  Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

Authors:  R J Jackson; A J Ramsay; C D Christensen; S Beaton; D F Hall; I A Ramshaw
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo.

Authors:  M S Rolph; W B Cowden; C J Medveczky; I A Ramshaw
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes.

Authors:  T Woodberry; J Gardner; L Mateo; D Eisen; J Medveczky; I A Ramshaw; S A Thomson; R A Ffrench; S L Elliott; H Firat; F A Lemonnier; A Suhrbier
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model.

Authors:  T A Brandt; B L Jacobs
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Expression of Drosophila Shaker potassium channels in mammalian cells infected with recombinant vaccinia virus.

Authors:  R J Leonard; A Karschin; S Jayashree-Aiyar; N Davidson; M A Tanouye; L Thomas; G Thomas; H A Lester
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells.

Authors:  Juan Carlos Gallego-Gómez; Cristina Risco; Dolores Rodríguez; Pilar Cabezas; Susana Guerra; José L Carrascosa; Mariano Esteban
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo.

Authors:  S Mahalingam; J M Farber; G Karupiah
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model.

Authors:  J Tufariello; S Cho; M S Horwitz
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

9.  Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence.

Authors:  J Zhou; X Y Sun; K Louis; I H Frazer
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

10.  Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo.

Authors:  D P Sharma; A J Ramsay; D J Maguire; M S Rolph; I A Ramshaw
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.